{
  "id": 16618815,
  "title": "Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs",
  "url": "https://urgent.news/2026/10/26/aspen-bambusa-target-135m-ipos-astrazeneca-vs-takeda-in-gastric",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T14:40:47.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/aspen-bambusa-target-135m-ipos-astrazeneca-vs-takeda-in-gastric-cancer-adcs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Hutchmed, Johnson & Johnson, Jazz Pharmaceuticals, Novartis, Roche and Oruka Therapeutics. Aspen, Bambusa both eye $135M IPOs: Aspen Neuroscience plans to sell 9.38 million shares {$ASPE} between $15 ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}